Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback